Tanaka Y - Search Results

1

Trial of Anifrolumab in Active Systemic Lupus Erythematosus.

Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. Among authors: tanaka y. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.

2

Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.

Tsujimura S, Saito K, Nakayamada S, Nakano K, Tanaka Y. Tsujimura S, et al. Among authors: tanaka y. Arthritis Rheum. 2005 Jun;52(6):1676-83. doi: 10.1002/art.21032. Arthritis Rheum. 2005. PMID: 15934077 Free article.

3

Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features.

Fujii Y, Fujii K, Iwata S, Suzuki K, Azuma T, Saito K, Tanaka Y. Fujii Y, et al. Among authors: tanaka y. Clin Immunol. 2006 Jun;119(3):297-306. doi: 10.1016/j.clim.2006.01.001. Epub 2006 Feb 28. Clin Immunol. 2006. PMID: 16503201

4

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Tokunaga M, Saito K, Kawabata D, Imura Y, Fujii T, Nakayamada S, Tsujimura S, Nawata M, Iwata S, Azuma T, Mimori T, Tanaka Y. Tokunaga M, et al. Among authors: tanaka y. Ann Rheum Dis. 2007 Apr;66(4):470-5. doi: 10.1136/ard.2006.057885. Epub 2006 Nov 15. Ann Rheum Dis. 2007. PMID: 17107983 Free PMC article. Clinical Trial.

5

A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.

Tanaka Y, Yamamoto K, Takeuchi T, Nishimoto N, Miyasaka N, Sumida T, Shima Y, Takada K, Matsumoto I, Saito K, Koike T. Tanaka Y, et al. Mod Rheumatol. 2007;17(3):191-7. doi: 10.1007/s10165-007-0565-z. Epub 2007 Jun 20. Mod Rheumatol. 2007. PMID: 17564773 Clinical Trial.

6

Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis.

Eguchi K, Saito K, Kondo M, Hidaka T, Ueki Y, Tanaka Y; LCAP Investigators in Kyushu College of Rheumatology (LIKCR). Eguchi K, et al. Among authors: tanaka y. Mod Rheumatol. 2007;17(6):481-5. doi: 10.1007/s10165-007-0630-7. Epub 2007 Dec 20. Mod Rheumatol. 2007. PMID: 18084700 Clinical Trial.

7

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2).

Tanaka Y, Takeuchi T, Inoue E, Saito K, Sekiguchi N, Sato E, Nawata M, Kameda H, Iwata S, Amano K, Yamanaka H. Tanaka Y, et al. Mod Rheumatol. 2008;18(2):146-52. doi: 10.1007/s10165-008-0026-3. Epub 2008 Feb 19. Mod Rheumatol. 2008. PMID: 18283523 Free PMC article.

8

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).

Takeuchi T, Yamanaka H, Inoue E, Nagasawa H, Nawata M, Ikari K, Saito K, Sekiguchi N, Sato E, Kameda H, Iwata S, Mochizuki T, Amano K, Tanaka Y. Takeuchi T, et al. Among authors: tanaka y. Mod Rheumatol. 2008;18(5):447-54. doi: 10.1007/s10165-008-0077-5. Epub 2008 May 21. Mod Rheumatol. 2008. PMID: 18493716

9

Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.

Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Takeuchi T; Japan Biological Agent Study Integrated Consortium. Kameda H, et al. Among authors: tanaka y. Mod Rheumatol. 2010 Dec;20(6):531-8. doi: 10.1007/s10165-010-0324-4. Epub 2010 Jun 24. Mod Rheumatol. 2010. PMID: 20574649 Clinical Trial.

10

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Hanami K, Tanaka Y. Iwata S, et al. Among authors: tanaka y. Mod Rheumatol. 2011 Apr;21(2):184-91. doi: 10.1007/s10165-010-0370-y. Epub 2010 Nov 5. Mod Rheumatol. 2011. PMID: 21052764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,008 results

Search Page